FDA Announces Meetings of Dermatologic and Ophthalmic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

Summary

The US Food and Drug Administration (FDA) has scheduled meetings of the Dermatologic and Ophthalmic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various topics related to drug safety and risk management